$41,169,014

Department of Health and Human Services·Office of Assistant Secretary for Preparedness and Response

biotechexpiring · 12d· period of performance ends in 12 daysONGOING · MOD OF 2021 CONTRACT

WORK BEGAN2021-02-01·LATEST ACTION2026-03-26·SOURCEUSASPENDING·SOURCE IDCONT_AWD_75A50121C00019_7505_-NONE-_-NONE-

Award description

A RAPID, ACCURATE, POC DISPOSABLE INFLUENZA AND SARS-COV-2 MOLECULAR DIAGNOSTIC

Verbatim from USAspending.gov. Capitalization, abbreviations, and codes are unchanged.

The Buildout's read

What the model surfaced from this award

Confidence: high

In plain English

Develop rapid, accurate point-of-care molecular diagnostic tests for influenza and SARS-CoV-2.

Sub-sectors

diagnostic-devicespandemic-preparednessmolecular-testing

Why this matters

Strengthens U.S. pandemic preparedness and diagnostic capacity for respiratory pathogens through advanced POC technology.

Supply-chain signal

Signals demand for disposable diagnostic cartridges, molecular reagents, and point-of-care device manufacturing capabilities.

U.S.–China competition angle

Reduces U.S. dependence on foreign diagnostic supply chains and establishes domestic rapid-testing capability amid pandemic competition.

Generated by award_classification v2.0.0 via claude-haiku-4-5-20251001 on 2026-05-15. Cost: $0.002191.

Period of performance

Start

2021-02-01

End

2026-05-31

Status

expiring · 12din 12 days

Recipient

Sources

USAspending.gov — all awards for this UEI →
SAM.gov entity registration →
Award record ingested from usaspending. Source identifier CONT_AWD_75A50121C00019_7505_-NONE-_-NONE-.

The Buildout does not edit federal records. Any inaccuracy reflects the upstream source; it will update here when corrected there.